| |
|
|
|
Cancer Genetics Inc.  
|
|
0.493 -0.045 (-0.08%) |
11-16 16:00 |
|
Open: |
0.522 |
Pre close: |
0.538 |
Target:
|
0.91 
|
|
High: |
0.548 |
Low: |
0.48 |
Resistance:
|
0.78
0.96
|
|
Volume: |
127,634 |
Market Cap: |
14M |
Support:
|
0.48
0.40
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.55
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
0.70 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
0.91 |
Stochastic Oscillator |
%K(14,3):
|
8.75 |
|
MA(250): |
1.31 |
%D(3): |
14.99 |
|
Average Volume(K) |
3-Month: |
17156
|
52-Week |
High:
|
2.75 |
|
10-Days: |
11673 |
Low: |
0.48 |
|
RSI |
RSI(14):
|
21.29 |
Change(%): |
-81.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.800 |
Return on Equity (ttm) |
-92.6 |
Shares Out. (M) |
27.75 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-40.4 |
Shares Float (M) |
24.48 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
-0.03 |
% Held by Insiders |
11.80 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
6.5 |
% Held by Institutions |
17.00 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.124 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.050 |
EBITDA (p.s.) |
0.009 |
P/E |
-0.62 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.47 |
|
Profit Margin |
-71.94 |
Operating Cash Flow
(M) |
-14.28 |
P/S |
11122561.00 |
|
Operating Margin |
-71.63 |
Levered Free Cash Flow
(M) |
-3.66 |
P/CF |
-0.96 |
|
|
|
|
|
|
